Purpose: To assess the role of Dynamic contrast enhanced magnetic resonance imaging in characterization of breast lesions and to differentiate benign from malignant lesions on the basis of their morphology and enhancement kinetics. Material and Methods: Sixty patients referred to the department of Radiodiagnosis for breast MRI over a period of twenty months were included. Dynamic contrast enhanced (DCE) Magnetic Resonance Imaging (MRI) was performed to differentiate breast lesions on the basis of morphology and enhancement kinetics. The lesions were classified accordingly into type I (progressive enhancement) Type II (plateau) and Type III (washout) kinetics. Morphology and curves of benign and malignant lesions were compared. Result: fifty one benign lesions were detected in 32 patients and 29 malignant lesions were seen in 22 patients, whereas six patients showed normal MRI.
Introduction
Breast MRI has been increasingly used in clinical practice. It has played important roles in breast cancer management, including ____________________________________ Corrospondence to: Dr. Pratibha Issar, J.L.N. Hospital & Research Centre, S.A.I.L., Bhilai, Qrt.No. 3B, S.P.A.Sector-9, Bhilai 490009 Chhattisgarh, India Email Id: mareesh_23@yahoo.co.in staging of breast cancer, monitoring of response to neoadjuvant chemotherapy, evaluation of patients with metastatic axillary lymph nodes with unknown primary tumor, screening of breast cancer in women at high risk, and problem solving when findings at mammography and Ultrasonography are inconclusive. 1, 2 Dynamic contrast enhanced (DCE) MR imaging with adequate spatial and temporal resolution, facilitated assessment of both morphologic and enhancement kinetic features, as are described in the Standardized American college of Radiology (ACR) breast imaging reporting and Data system (BI-RADS) MR Imaging Lexicon. New revisions of the MRI lexicon serve to further clarify breast MR imaging reporting, improve lesion diagnosis and management and facilitate patient care. 3, 4 The goal of the study was to assess the role of Dynamic contrast enhanced magnetic resonance imaging in characterization of breast lesions and to differentiate benign from malignant lesions on the basis of their morphology and signal intensity curve.
Material and Methods
This is a prospective study of sixty consecutive patients (age distribution 24 to 75 years) from June 2012 to January 2014. Inclusion criteria for the study were presence of indeterminate masses on mammography and /or ultrasound, follow up of breast cancer, post-operative scar, nipple discharge and ulceration, breast infection, dense breast on X-Ray mammogram, screening tool for breast cancer in high risk females and in patient with metastatic axillary lymph node with unknown primary. Exclusion criteria were patient with normal X-Ray mammogram and ultrasound. All diagnosis was confirmed by FNAC/biopsy mostly with ultrasound guidance, wherever possible or required. Most of the MR examination was performed during the second phase of menstrual cycle (Days 7-14), except in cases of suspected malignancy. The indications for breast MRI are summarized in Table1.
Breast MR was done with eight channel double breast coil in prone position using Signa Excite 1.5 Tesla MRI machine GE Healthcare (advantage window 4.0 GE Healthcare). Subtraction images were obtained after subtraction of unenhanced images from contrast enhanced images. Time signal intensity curves (Kinetic curves) for abnormal finding were obtained by placing ROI (Region of interest) over required area. MIP (Maximum intensity projection) images were also obtained. The MR technique is summarized in Table 2 .
Contrast material was injected I.V (0.1mmol/Kg of Gadiodiamide (Omniscan, GE healthcare) and followed by a 20 ml saline flush at a rate of 2ml /sec, For dynamic study-unenhanced images were obtained follow by 6 series of enhanced images. Dynamic contrast images were reviewed at a workstation (Advantage Window 4.0 G.E.Healthcare). Equal matrixsize subtraction images of the unenhanced and contrast-enhanced images were used.Time signal intensity curves for abnormal findings were calculated from the dynamic study. All lesions were reported according to the BI-RADS lexicon for MRI on the basis of their morphologic features and kinetics of contrast enhancement.
Data Analysis

Result
Out of sixty cases, thirty eight cases were benign in nature which includes six normal cases whereas malignancy was detected in twenty two cases. Background parenchymal enhancement (BPE) of breast lesions were categorized on the basis of both amount and the degree of normal parenchyma enhancement on the first contrast enhanced MR imaging sequence. BPE was noticed as minimal-less than 25% of enhancement (8 cases), mild-25% to 50% of enhancement (17 cases), moderate-50% to 75% of enhancement (23 cases) and marked-more than 75% of enhancement (7 cases). MRI morphologic features of MRI detected lesions are summarized in Table 3 and associated findings in Table 4 .
Simple fibro adenomas were round or oval in shape ( Type I progressive curve. One case of fibro adenoma with micro calcification on mammography showed oval well defined lesion with heterogeneous enhancement and type I benign progressive curve on kinetic enhancement ( Fig. 2A and B) . A case of fibro cystic disease showed intra cystic projection with areas of increase vascularity. On DEC MRI, peripheral enhancement with few enhancing septas were seen on medial aspect with type II curve, a suspicious lesion, on lumpectomy turned out to be a fibro cystic disease with ductal cell hyperplasia (Fig.3A and B) . Three cases of clinically suspicious Paget's disease of nipple were seen, all of them were Fig.4A and B) , while intra ductal linear subaerolar calcification seen on mammography in one case. Linear enhancing dilated sub aerolar ductal system with two small enhancing lesion within it seen in one case turn out to be high grade ductal carcinoma in situ with intra ductal papilloma ( 5 x 8 x 6.7mm) and type II curve ( Fig. 5A and B) . Malignant lesions were irregular in shape with irregular or spiculated margins and were showing heterogeneous enhancement with mainly type III curve and associated findings of skin, nipple retraction and lymphadenopathy ( Fig.6 and 7A and B). The sensitivity and specificity for diagnosis of malignant lesion was 100% and 95.65%.
One case of malignant lesion involving both breasts was noticed in 75 year male with no family history of breast cancer ( Fig. 8A and  B) . Breast cancer can occur in unusual sites also. In our study a Fifty three old woman showed irregularly heterogeneous enhancing lesion anterior to left pectoral muscle with normal enhancing intra-mammary lymph node and Type I curve. On the basis of morphology it was diagnose as a malignant lesion and turned out to be high grade ductal carcinoma in situ ( Fig.9 A and B) . A case of post-operative carcinoma right breast on follow up MRI showed invasive ductal carcinoma in left breast with type II curve ( Fig. 10A and B) . The pathological findings of MRI Detected lesions are summarized in Table 5 . After evaluating lesion morphology and kinetics, they were classified according to MRI BI-RAD Lexicon, Category 1 (6 cases), Category 2(24 cases), Category 3 (7 cases), Category 4 (1case), Category 5 (15 cases) and Category 6 (7 cases). 
Discussion
Dynamic contrast enhanced MRI is useful for characterization of breast lesions and additional information derived from kinetic curve type to architectural features of a lesion improves the specificity of MRI. Fibrocystic changes (FCC) of the breast are a benign breast disease affecting more than 50% of women. FCC with epithelial proliferation has been associated with an increased risk of subsequent breast cancer especially if accompanied with atypical cellular changes. MRI helps to exclude breast Cancer and premalignant lesions in FCC patients and facilitate to decrease unnecessary biopsy rate for an actually benign condition 5, 6 . In our study most of the patients showed single or multiple foci of benign enhancement and two patients showed non mass enhancement. Most of the patients showed type I curve whereas type II curve was noticed in one patient associated with ductal cell hyperplasia.
Fibroadenomas are the most common benign tumor in young women, with increasing age water content of these tumor decreases and fibrotic component increases. 7, 8 They were mainly seen as round or oval lesions with homogenous enhancement and type I curve. Six of our cases were showing heterogeneous enhancement with well define margin and type II curve.
In our study we saw seven cases of ductal carcinoma in situ (DCIS), out of that two were seen as nonmass enhancing lesion. All mass like lesion were Irregular in shape and curve predominantly showing plateau (6 cases) followed be persistent kinetic curve in one case. These finding were concordant with those in previous study performed by Jeong Ahkin and et al. 9 Tumor angiogenesis is a critical factor in breast tumor growth and aggressiveness. Neovascularizations of pure DCIS lesions result in early rapid contrast uptake and that tumor angiogenesis and structural abnormality of vessels in pure DCIS lesions are more prominent than in benign lesions but less prominent than in invasive malignant tumor. Invasive ductal carcinoma is the most common primary malignant tumors of the breast. MRI demonstrated an irregular shaped, spiculated mass with rim or heterogeneous enhancement with mostly type II or type III curve. 12 Our study also showed similar findings reported by Gurpreet S. Dhillon. 13 We saw seven cases of invasive ductal carcinoma with type III curve.
Medullary carcinoma of the breast is a rare invasive breast malignancy and accounts for fewer than 5% of breast carcinomas. 14 Diffusion Weighted imaging (DWI) is used to improve the specificity of MRI for the evaluation of breast lesions. By using the DWI sequences, one can calculate the apparent diffusion coefficient (ADC), a quantitative measure that is directly proportional to the water diffusion. High cell proliferation in malignant tumors increases cellular density, creating more barriers to the extra cellular water diffusion, reducing the ADC, and resulting in signal loss. This sequence appears to be a useful tool for tumor detection and characterization as well as monitoring and predicting treatment response. 16, 17 In our study the mean ADC obtained from malignant breast lesions was significantdly lower than that observed in benign lesions.
Conclusion
By evaluating the morphology and kinetic features of different breast lesions in our study the following guide lines have emerged which is demonstrated in a flow chart no I .
1. If morphology suggests a benign lesion with type I time course than it support the diagnosis of a benign lesion and may be used to preclude the performance of biopsy.
2. If morphology suggests a probably benign or indeterminate lesion, but a plateau or washout time curve is detected, biopsy must be performed on the lesion. A washout constitute an absolute indication to perform biopsy irrespective of other MR criteria particularly morphology.
3. If morphology suggests a malignant lesion then kinetic does not have much role, it can only help to confirm the presence of breast cancer with washout kinetics. Type I signal intensity curve
